US45168D1046 - Common Stock
531.35 +8.27 (+1.58%)
After market: 531.35 0 (0%)
IDEXX LABORATORIES INC
NASDAQ:IDXX (12/8/2023, 7:00:02 PM)After market: 531.35 0 (0%)
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 10,780 full-time employees. The company also offers human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment provides products and services for veterinarians and the biomedical research community, primarily related to diagnostics and information management. The Water segment provides testing solutions for the detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry. The firm has sales offices outside the United States in all regions, including Africa, Asia Pacific, Canada, Europe, the Middle East, and Latin America.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092
CEO: Jonathan J. Mazelsky
On Wednesday, IDEXX Laboratories now stock clears the 80-plus Relative Strength Rating threshold, with a jump from 79 to 83.
The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77.
What's going on in today's session: S&P500 movers
Here you can normally see the latest stock twits on IDXX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.